Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
22.6%
% of PTH's 53 holdings also in SBIO
14.0%
% of SBIO's 87 holdings also in PTH
Overlap by Weight
Sector Drift (PTH minus SBIO)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in PTH |
Weight in SBIO |
Overlap | |
---|---|---|---|---|
IDEAYA BIOSCIENCES, INC. | 2.2% | 2.0% | 2.0% | |
VAXCYTE, INC. | 1.6% | 4.6% | 1.6% | |
MERUS N.V. | 1.5% | 1.6% | 1.5% | |
CRINETICS PHARMACEUTICALS INC | 1.5% | 2.1% | 1.5% | |
VERA THERAPEUTICS, INC. CLASS A | 2.6% | 1.4% | 1.4% |
Position Highlights (Non-Overlapping Exposures)
PTH Overweight Relative to SBIO
ELI LILLY & CO | 5.1% | |
IDEXX LABORATORIES INC | 4.6% | |
MEDPACE HOLDINGS, INC. | 4.4% | |
TENET HEALTHCARE CORP | 3.0% | |
AMERISOURCEBERGEN CORP | 2.9% | |
MOLINA HEALTHCARE INC | 2.8% | |
REGENERON PHARMACEUTICALS | 2.7% | |
NATERA INC | 2.7% | |
ABBVIE INC | 2.6% | |
DAVITA INC | 2.5% |
PTH Underweight Relative to SBIO
VIKING THERAPEUTICS, INC. | -5.3% | |
CEREVEL THERAPEUTICS HOLDINGS INC | -4.8% | |
REVOLUTION MEDICINES, INC. | -3.1% | |
VAXCYTE, INC. | -3.0% | |
ALKERMES PLC | -2.8% | |
ARCELLX, INC. | -2.3% | |
AXSOME THERAPEUTICS, INC. | -2.3% | |
XENON PHARMACEUTICALS INC. | -2.0% | |
IMMUNOCORE HOLDINGS PLC SPONSORED AD | -1.9% | |
MOONLAKE IMMUNOTHERAPEUTICS CLASS A | -1.9% |